SP, Author at Solitek

Solitek Unveils Advisory Board Featuring Renowned Pharmaceutical Experts Sudhakar Garad and Michael Wilkins

Barcelona, September 5th, 2023Solid Technologies SL (aka ‘Solitek’), a pioneering pharmaceutical and preclinical formulation development company, is thrilled to announce the establishment of its distinguished Advisory Board. Comprised of seasoned industry leaders, this esteemed panel of experts will bolster Solitek’s commitment to advancing pharmaceutical solutions and driving innovation in the field of preclinical development. The …

Solitek Unveils Advisory Board Featuring Renowned Pharmaceutical Experts Sudhakar Garad and Michael Wilkins Read More »

Solitek forge Strategic Partnership with Agility Life Sciences

News / By SP

We are excited to announce a new partnership with Agility Life Sciences.
An agreement designed to offer a larger portfolio of services to our clients.

Reflections on a Developability Assessment Program

Resources / By SP

Patients may be missing out on innovative therapies. After having worked for many years in the design and development of novel active ingredients, this is a difficult fact to accept, but a fact, nevertheless.

AGQ Labs and Solitek sign a commercial agreement for the distribution of analytical and specialized consulting services.

Collaborations, News / By SP

AGQ labs and Solitek join forces in a commercial agreement for the distribution of analytical services and specialized advice in the development of solid forms. These services are of common application in the pharmaceutical sector, but their introduction in other industries, such as agrochemical or food supplements, can potentially bring significant advantages to the earlier implementers.

Crystallization Development A – QbD Approach to PSD Control using Modelling

Resources / By SP

Abstract An approach to crystallization development is described, based on a mixture of theoretical modelling and experimentation that provides a deep understanding of the process factors that influence PSD and improves efficiency in development and … Introduction Nearly all synthetic steps in industrial chemical manufacturing end with a crystallization. This is because it is almost …

Crystallization Development A – QbD Approach to PSD Control using Modelling Read More »

Charnwood Molecular and Solitek launch a collaboration combining expertise in drug discovery and development

Collaborations, News / By SP

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has added a range of new solid-state capabilities to its portfolio through a new collaborative partnership with Barcelona-based Solitek.

Solitek Sets up in the Scientific Park of Barcelona

News / By SP

Welcome to a new concept in solid state development services that will help you bring innovative solutions to the market. Solitek brings a new concept in solid state development, combining an excellent understanding of the diversity of the solid form landscape exhibited by small molecule organic compounds with experience and practical know-how, increasing your chances …

Solitek Sets up in the Scientific Park of Barcelona Read More »